CD47–SIRPα signaling is involved in the development of diseases including cancer, and since short SIRPα is expressed as widely as long SIRPα, we believe that these findings will provide important perspectives into the mechanisms of onset and the development of treatments for these diseases. Here, CD47 is linked to cancer.